Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.

The nonobese diabetic (NOD) mouse is a classical animal model for autoimmune type 1 diabetes (T1D), closely mimicking features of human T1D. Thus, the NOD mouse presents an opportunity to test the effectiveness of induced pluripotent stem cells (iPSCs) as a therapeutic modality for T1D. Here, we demonstrate a proof of concept for cellular therapy using NOD mouse-derived iPSCs (NOD-iPSCs). We generated iPSCs from NOD mouse embryonic fibroblasts or NOD mouse pancreas-derived epithelial cells (NPEs), and applied directed differentiation protocols to differentiate the NOD-iPSCs toward functional pancreatic beta cells. Finally, we investigated whether the NPE-iPSC-derived insulin-producing cells could normalize hyperglycemia in transplanted diabetic mice. The NOD-iPSCs showed typical embryonic stem cell-like characteristics such as expression of markers for pluripotency, in vitro differentiation, teratoma formation, and generation of chimeric mice. We developed a method for stepwise differentiation of NOD-iPSCs into insulin-producing cells, and found that NPE-iPSCs differentiate more readily into insulin-producing cells. The differentiated NPE-iPSCs expressed diverse pancreatic beta cell markers and released insulin in response to glucose and KCl stimulation. Transplantation of the differentiated NPE-iPSCs into diabetic mice resulted in kidney engraftment. The engrafted cells responded to glucose by secreting insulin, thereby normalizing blood glucose levels. We propose that NOD-iPSCs will provide a useful tool for investigating genetic susceptibility to autoimmune diseases and generating a cellular interaction model of T1D, paving the way for the potential application of patient-derived iPSCs in autologous beta cell transplantation for treating diabetes.

[1]  C. Lengner,et al.  Metastable Pluripotent States in NOD-Mouse-Derived ESCs , 2015 .

[2]  Ssang-Goo Cho,et al.  The generation of iPS cells using non-viral magnetic nanoparticle based transfection. , 2011, Biomaterials.

[3]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[4]  N. Benvenisty,et al.  Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.

[5]  E. Hayden.  Stem cells: The growing pains of pluripotency , 2011, Nature.

[6]  Jonathan A. Javitch,et al.  Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homolog , 2011, Nature.

[7]  Gonçalo Castelo-Branco,et al.  Nanog Overcomes Reprogramming Barriers and Induces Pluripotency in Minimal Conditions , 2011, Current Biology.

[8]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[9]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[10]  M. Côrrea-Giannella,et al.  Pancreatic islet transplantation , 2009, Diabetology & metabolic syndrome.

[11]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[12]  Alan Colman,et al.  Pluripotent stem cells and disease modeling. , 2009, Cell stem cell.

[13]  A. Tobar,et al.  Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model , 2009, Proceedings of the National Academy of Sciences.

[14]  Hong Chen,et al.  The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. , 2009, Immunobiology.

[15]  Wei Jiang,et al.  Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells , 2009, Cell Research.

[16]  Mohamed H. Sayegh,et al.  Immunomodulation by Mesenchymal Stem Cells , 2008, Diabetes.

[17]  L. Rubin.  Stem Cells and Drug Discovery: The Beginning of a New Era? , 2008, Cell.

[18]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[19]  Jae Hoon Kim,et al.  Simple, efficient, and reproducible gene transfection of mouse embryonic stem cells by magnetofection. , 2008, Stem cells and development.

[20]  G. Szot,et al.  Murine pancreatic islet isolation. , 2007, Journal of visualized experiments : JoVE.

[21]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[22]  N. Wulffraat,et al.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 , 2007, Arthritis research & therapy.

[23]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[24]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[25]  U. Christians,et al.  Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates , 2006, Nature Medicine.

[26]  L. Hsiao,et al.  Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. , 2005, The Journal of clinical investigation.

[27]  H. Garchon,et al.  Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. , 2004, Diabetes.

[28]  N. Perico,et al.  Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.

[29]  L. Chatenoud,et al.  Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Melov,et al.  Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts , 2003, Nature Cell Biology.

[31]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[32]  L. Chatenoud,et al.  Long-Term Reversal of Established Autoimmunity upon Transient Blockade of the LFA-1/Intercellular Adhesion Molecule-1 Pathway1 , 2002, The Journal of Immunology.

[33]  A. Shapiro,et al.  Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. , 2002, Diabetes.

[34]  Y. Nakajima,et al.  In Vitro Differentiation of Embryonic Stem Cells into Hepatocyte‐Like Cells Identified by Cellular Uptake of Indocyanine Green , 2002, Stem cells.

[35]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[36]  D. Schoenfeld,et al.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. , 2001, The Journal of clinical investigation.

[37]  J. Bluestone,et al.  Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor , 2001, The Journal of experimental medicine.

[38]  G. Korbutt,et al.  SINGLE INJECTION OF INSULIN DELAYS THE RECURRENCE OF DIABETES IN SYNGENEIC ISLET-TRANSPLANTED DIABETIC NOD MICE 1 , 2000, Transplantation.

[39]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[40]  M. Atkinson,et al.  The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.

[41]  Y. Kim,et al.  Apoptosis of pancreatic β‐cells detected in accelerated diabetes of NOD mice: no role of Fas‐Fas ligand interaction in autoimmune diabetes , 1999, European journal of immunology.

[42]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[43]  S. Genuth,et al.  Pancreas transplantation for type I diabetes , 1998 .

[44]  Bhagirath Singh,et al.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.

[45]  D. Eizirik,et al.  IL‐1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non‐obese diabetic (NOD) mice , 1997, Clinical and experimental immunology.

[46]  L. Chatenoud,et al.  CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. , 1997, Journal of immunology.

[47]  J. Lakey,et al.  BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. , 1994, Transplantation.

[48]  D. Hanahan,et al.  Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. , 1993, Development.

[49]  G. Warnock,et al.  Prevention of Recurrence of IDDM in Islet-Transplanted Diabetic NOD Mice by Adjuvant Immunotherapy , 1992, Diabetes.

[50]  W. Bolton,et al.  Preparation of primary monolayer cultures of mouse pancreatic epithelial cells , 1982 .

[51]  J. Borneman,et al.  Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson ' s disease , 2009 .

[52]  A. Shapiro,et al.  Current status of clinical islet cell transplantation. , 2006, Methods in molecular biology.

[53]  Kara Hunter,et al.  Type 1 diabetes genes and pathways shared by humans and NOD mice. , 2005, Journal of autoimmunity.

[54]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[55]  J. Todd,et al.  The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome. , 2003, Diabetes.

[56]  M. Uskoković,et al.  A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. , 2002, Diabetes.

[57]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[58]  S. Genuth,et al.  Therapeutic controversy: Pancreas transplantation for type I diabetes. , 1998, The Journal of clinical endocrinology and metabolism.